calendar
1 catalysts · 32 phase 2 completion · 25 phase 1 completion · 21 phase 1 2 completion · 15 phase 1 initiation · 9 phase 1 2 initiation · 8 phase 0 trial completion
next 91 dayslessmore
MonWedFri
1 catalysts · 32 phase 2 completion · 25 phase 1 completion · 21 phase 1 2 completion · 15 phase 1 initiation · 9 phase 1 2 initiation · 8 phase 0 trial completion
Therapy area: Oncology. Indication: Hormone-Sensitive Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Prostate Cancer, Prostate Cancer